If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Business Update

27 Sep 2010 07:00

RNS Number : 3114T
Ashley House PLC
27 September 2010
 



 

 

 

 

Business Update

Dividend update

 

The Board of Ashley House plc, the primary care infrastructure specialist, has decided ahead of its AGM today that it is prudent to withdraw the resolution to approve the final dividend payment due on 29 October. However, the Company intends to declare and pay a special interim dividend at the earliest opportunity.

 

This decision is the result of the lack of conclusion on a second bid approach in recent months for the company's property partner AH Medical Properties plc (AHMP). Release of fees and confirmation of available funding for the construction of four schemes which AHMP has an option to purchase under the Asset Management Agreement had been expected by the end of October. Together with current cash of £800k this would have increased the Company's cash balances to a level more than sufficient to cover the dividend requirement of £1.7m. The Board hopes that the AHMP bid situation will be resolved shortly and is confident that new funding arrangements for Ashley House schemes will be in place soon; however with no certainty on payment dates it would be imprudent to commit to a dividend payment date at this point in time.

 

The Board will provide an update on the special dividend payment as soon as it is able to do so.

 

Scheme progress

 

The Company is pleased to announce that 2 LIFT schemes with a Design and Build value of c. £8m in East London have achieved financial close. These schemes in Tower Hamlets and Hackney have been much delayed but their move to close is reassuring in the light of the current public sector spending environment.

 

Including these 2 schemes, the Company now has 9 schemes in the construction phase with a design and build value of just over £30m. This is the highest value in on site schemes the Company has ever recorded with a significant number of further projects set to move into the construction phase in the second half.

 

 

Outlook

 

The Company's operational performance this year is expected to be in line with management's expectations, based on the levels of current activity and the pipeline of schemes set to move to site in the second half of the year.

 

The White Paper, Equity and Excellence: Liberating the NHS, published on 12 July was more radical than expected in transferring healthcare commissioning to GPs and announcing the abolition of PCTs by 2013. Whilst this may well be of long term benefit to Ashley House given our strength in the GP market, it will inevitably mean the current slow pace in approving schemes continues. There was no reference in the White Paper to healthcare estates or to LIFT, where the company has a leading presence. We continue to monitor the debate in Government on how to make best use of the healthcare estate and are contributing wherever possible.

 

In the light of the White Paper the Company is currently analysing the potential impact on its Public sector partners and assessing any possible consequences for the carrying values of its relevant assets.

 

Jonathan Holmes, CEO commented: 'Despite the challenges arising from the changing healthcare landscape and from uncertainties surrounding the future ownership of our property partner AH Medical Properties affecting our short term ability to fund new schemes, we are delivering positive operational performance and remain confident about the long term prospects of the sector and our business'.

 

ENDS

 

Enquiries:

Ashley House plc

Jonathan Holmes, Chief Executive

Tony Walters, Finance Director

 

Tel: 01628 600340

Numis Securities

(NOMAD and broker to Ashley House) 

Oliver Cardigan/ Simon Blank/ David Poutney

 

Tel: 020 7260 1000

Citigate Dewe Rogerson

Sarah Gestetner/ Ged Brumby

Tel: 020 7638 9571

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSONRROAKUAR
Date   Source Headline
29th Jun 20189:08 amRNSDirectorate change
10th May 20187:00 amRNSHolding(s) in Company
9th May 20182:05 pmRNSSecond Price Monitoring Extn
9th May 20182:00 pmRNSPrice Monitoring Extension
9th May 20187:00 amRNSTrading Update
3rd May 20185:38 pmRNSDirector/PDMR Shareholding
6th Mar 20183:00 pmRNSDirector Dealing
5th Mar 20187:00 amRNSFinancial Close Scarborough Extra Care
1st Mar 20187:00 amRNSAppointment of Finance Director
23rd Feb 201811:54 amRNSHolding(s) in Company
14th Feb 20188:51 amRNSSale of Pharmacy Interest to Repay Debt - Amended
14th Feb 20187:00 amRNSSale of Pharmacy Interest to Repay Debt
2nd Feb 20189:32 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSInterim Results
30th Jan 20184:31 pmRNSDirectors' & PDMRs' Dealings
22nd Dec 20171:07 pmRNSDirector/PDMR Shareholding
15th Dec 20171:56 pmRNSJoint Venture with Morgan Sindall Investments Ltd
24th Nov 20177:00 amRNSUpdate
7th Nov 201711:00 amRNSHolding(s) in Company
31st Oct 20172:28 pmRNSDirectors' & PDMRs' Dealings
26th Oct 20177:00 amRNSUpdate
25th Oct 201712:35 pmRNSResult of AGM
3rd Oct 201710:45 amRNSHolding(s) in Company
3rd Oct 20179:25 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreliminary Results For The Year End 30 April 2017
28th Jul 20174:45 pmRNSDirectors' & PDMRs' Dealings
4th Jul 20174:27 pmRNSDebt Facility from Related Party
28th Apr 20172:20 pmRNSDirectors' & PDMRs' dealings
25th Apr 20173:16 pmRNSDebt Facility from Related Party
27th Mar 201711:09 amRNSDirector Dealing
17th Mar 20173:42 pmRNSDirector Dealing
14th Mar 20171:11 pmRNSAcquisition and Trading Update
22nd Feb 201712:03 pmRNSPosting of Interim Report
30th Jan 20171:27 pmRNSDirectors' & PDMRs' dealings
26th Jan 20177:00 amRNSInterim Report 2016
17th Jan 201710:27 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSReplacement Debt Facility from Related Party
28th Oct 20168:41 amRNSDirectors' & PDMRs' dealings
15th Sep 201610:48 amRNSResult of AGM
23rd Aug 20167:00 amRNSReport and Accounts / AGM
28th Jul 20167:00 amRNSDirectors' & PDMRs' Dealings
13th Jul 201611:58 amRNSDirector/PDMR Shareholding
13th Jul 20167:00 amRNSPreliminary results
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 201610:22 amRNSDirectors' & PDMRs' dealings
29th Mar 20167:00 amRNSDirectors & PDMRs dealings
1st Mar 201611:09 amRNSDirector Dealing
10th Feb 20167:00 amRNSAdmission Application Announcement
5th Feb 20165:27 pmRNSPosting of Interim Report
26th Jan 20167:00 amRNSInterim Report 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.